EKF Diagnostics Holdings plc

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 11:35:27 2024-04-25 am EDT			5-day change	1st Jan Change
27.8 ^GBX	+0.18%		+1.46%	-12.16%

Apr. 11	Onward Opportunities' small-cap strategy yields solid results in 2023	AN
Mar. 20	EKF Diagnostics says prospects "promising" but pauses dividends	AN

Ekf Diagnostics : at MEDLAB - February 2018

December 04, 2017 at 12:07 pm EST

EKF Diagnostics will be exhibiting at MEDLAB Middle East 2018 showcasing our latest data management solutions for the DiaSpect Tm hemoglobin analyzer and Quo-Test HbA1c analyzer. Diabetes is a growing health concern in the Middle East and EKF offer a range of innovative point-of-care solutions. Come to our stand Z2.J31 to learn more.

MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. This year the Middle East show is set to welcome over 600 exhibitors and more than 25,000 attendees from 129+ countries.

Staff attending

Steven Wray | EMEA Sales Director

Paul Asmar | Regional Sales Manager (Middle East / Central Africa

Rajneesh Mahajan | Regional Sales Manager (India / SAARC)

Products on display

EKF Diagnostics Holdings plc published this content on 04 December 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 04 December 2017 17:06:01 UTC.

Original documenthttps://www.ekfdiagnostics.com/ekf-at-medlab-february-2018.html

Public permalinkhttp://www.publicnow.com/view/E59514564843CB910E62B4ECA7C1E737CF2D2360

Latest news about EKF Diagnostics Holdings plc

Onward Opportunities' small-cap strategy yields solid results in 2023	Apr. 11	AN
EKF Diagnostics says prospects "promising" but pauses dividends	Mar. 20	AN
EKF Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
EKF Diagnostics reports trading in line with expectations	Jan. 29	AN
EKF Diagnostics Holdings plc Provides Earnings Guidance for the Full Year 2023	Jan. 29	CI
EKF Diagnostics Holdings plc Announces the Official Opening of its New State-Of-The-Art Life Sciences Manufacturing Site in South Bend, Indiana, United States	23-10-26	CI
EARNINGS: FireAngel Safety interim loss widens amid ongoing headwinds	23-09-26	AN
Earnings Flash (EKF.L) EKF DIAGNOSTICS HOLDINGS Reports H1 Revenue GBP26.9M	23-09-26	MT
EKF Diagnostics Holdings plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26	CI
FTSE 100 Closes Tuesday Up 0.41% as Oil-Price Rises Benefit the Index	23-09-12	DJ
EKF Diagnostics hires CFO from Trellus Health, latter names successor	23-09-12	AN
FTSE 100 Rises, Led by AB Foods; Smurfit Kappa Slides	23-09-12	DJ
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics	23-09-12	MT
EKF Diagnostics Holdings plc Provides Financial Guidance for the Year Ending 31 December 2023	23-09-12	CI
EKF Diagnostics Holdings plc Appoints Stephen Young as Chief Financial Officer	23-09-12	CI
Revolution Bars reports good progress from Peach Pubs	23-07-26	AN
FTSE 100 Closes Down 0.2% as Miners Offset Ocado, -2-	23-07-26	DJ
FTSE 100 Closes Up 0.5% as Sage Group Shines	23-06-28	DJ
SONIA Illiquidity Could Explain Disconnect in BOE Peak Rate Pricing	23-06-28	DJ
EKF Diagnostics says CFO Davies resigns to pursue other opportunities	23-06-28	AN
EKF Diagnostics CFO Plans Exit; Successor to Assume Role in Q4	23-06-28	MT
Marc Davies to Step Down as Chief Financial Officer of EKF Diagnostics Holdings plc	23-06-28	CI
EKF Diagnostics announces enzyme fermenter progress	23-06-20	AN
EKF Diagnostics' Enzyme Fermenter Completes Factory Acceptance Testing	23-06-20	MT
EKF Diagnostics Holdings plc Announces Its Life Sciences Division's New 14,500L Enzyme Fermentation Capacity Expansion Progress	23-06-20	CI

Chart EKF Diagnostics Holdings plc

Duration

Period

More charts

Company Profile

EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-14 - Annual General Meeting

More about the company